Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): Geographic region subgroups in EMPOWER-Lung 1

Ho G. F., Sezer A., Kilickap S., GÜMÜŞ M., Bondarenko I., ÖZGÜROĞLU M., ...More

ESMO Asia Congress, Singapore, Singapore, 2 - 04 December 2022

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1016/j.annonc.2022.10.372
  • City: Singapore
  • Country: Singapore
  • Istanbul University Affiliated: No